Free Webinar - "Drug Shortages: Weathering the Storm" with Paul Arpino, PharmD, BCPS - Wednesday, March 21, 2012, 2:00 PM Eastern. Reserve your seat now.
It looks like 2012 is shaping up to be a good year for pharmacists! U.S. News & World Report named pharmacists as one of the top jobs of 2012 with more than 69,000 pharmacist positions projected to be added by 2020. Key factors in the high rating included the aging population, demand for complex medicines and medication therapy management.
Pharmacists are critical for improving medication therapy management and patient outcomes. Last week, ASHP and APhA released a white paper, "Improving Care Transitions: Optimizing Medication Reconciliation," which highlights the need for pharmacists to take leadership in implementing medication reconciliation. Applying a standardized approach will help cut down on medication errors - when approximately half of them are attributed to communication at transitions of care.
The white paper indicated a strong medication reconciliation strategy users HIT solutions to help share important clinical information. Sentri7 can help identify and alert staff of possible intervention opportunities at the point of patient monitoring. Get more information on Sentri7.
Medication reconciliation is just one of the hot topics at the annual APhA meeting in New Orleans. We'll be following the conversation today on Twitter.
The conclusion to our previous poll: 13 percent of pharmacist poll respondents have more than 2 FTEs dedicated to shortage workarounds; 48 percent have none.
As a pharmacist, you have options when it comes to where you work, and the team at PharmacyWeek sees several pharmacy job opportunities cross their desks every day that make them want to get up and go work at these dream destinations. Jet Setter Pharmacist highlights great job openings in even better locations, and what makes these locations and employers so unique!
India's Dr. Reddy's get U.S. nod for schizophrenia capsules Reuters
Glenmark gets FDA nod for Imiquimod cream PharmaBiz
4. CMS Plan to Restrict Sale of Pain Drugs Opposed by AMA
A federal plan calling for Medicare Advantage Part D sponsors to deny potentially unsafe pain drugs such as hydrocodone and oxycodone—perhaps to patients who may be "doctor shopping"—has incurred strong objection from the American Medical Association. Get the full story from Health Leaders Media.
5. Could a NOSH-Aspirin-A-Day Keep Cancer Away?
The humble aspirin may soon have a new role. Scientists from The City College of New York have developed a new aspirin compound that has great promise to be not only an extremely potent cancer-fighter, but even safer than the classic medicine cabinet staple. Get the full story from Science Daily.
6. Discussion: Pharmacy Practice - Decontamination of Hazardous Preparations
"Is there any data on what the optimal percentage of sodium hypochlorite is needed to decontaminate chemotherapy? Is 0.5% enough or do you need at least 2% as was in Surface safe?" (read entire post/reply)
7. Top News Story Last Week: Death magnifies Pradaxa hemorrhage concerns
The death of an elderly man from a massive brain hemorrhage after a routine fall suggests that bleeding complications from Boehringer Ingelheim's Pradaxa blood clot preventer are largely irreversible, according to the Journal of Neurosurgery. View last week's news review.
HELIDAC
STATINS & HIV OR HCV
NORGESTIMATE & ETHINYL ESTRADIOL
E-mail This Newsletter to a Friend
